Skip to main content
. 2016 Feb 9;2016:150131. doi: 10.1530/EDM-15-0131

Table 1.

Thyroid function tests, autoantibodies and pharmacological treatment during follow-up

Reference values 2012 2013 2014 2015
June March September February 3rd June 6th June * August October January April July
TSH (mU/l) 0.6–6.4 μU/l 0.11 1.1 0.026 0.027 46 14.2 0.018 0.016 1.21 0.008 <0.004
T4 (ng/dl) 0.8–1.99 1.99 1.054 1.5 1.3 0.5 0.6 2.8 2.1 1.0 1.9 3.1
T3 (pg/ml) 1.4–4.4 3.5 11.0 6.4 5.8
TPO Abs (UI/ml) < 35 496.2 7786.5 10848.7 6235.5 >1000 >1000 >1000 948
TRAbs (UI/l) <14 4.1 10.8 32.9 20
Levothyroxine (μg/kg per day) 0.37 0.18 0.73 0.73 0.73 0.73 0.73 0.37
Methimazole (mg/kg per day) 0.15 0.20 0.20 0.20 0.23
*

Scintigraphic findings of homogeneously increased iodine uptake, suggestive of Graves' disease.

Serum sample where bioassay to estimate TSAbs and TBAbs biological activity was performed.